Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis

Early eradication treatment with inhaled tobramycin is successful in the majority of children with cystic fibrosis (CF) with incident Pseudomonas aeruginosa infection. However, in 10–40 % of cases, eradication fails and the reasons for this are poorly understood. The purpose of this study was to det...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical microbiology & infectious diseases 2016-01, Vol.35 (1), p.67-74
Hauptverfasser:	Vidya, P., Smith, L., Beaudoin, T., Yau, Y. C. W., Clark, S., Coburn, B., Guttman, D. S., Hwang, D. M., Waters, V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Anti-Bacterial Agents - therapeutic use Biofilms Biomedical and Life Sciences Biomedicine Canada Child Child, Preschool Cross-Sectional Studies Cystic fibrosis Cystic Fibrosis - complications Drug Resistance, Bacterial Failure Female Gene Deletion Health care networks Hospitals Humans Infections Internal Medicine Laboratories Locomotion Male Medical Microbiology Microbial Sensitivity Tests Original Article Patients Phenotype Polysaccharides, Bacterial - secretion Pseudomonas aeruginosa Pseudomonas aeruginosa - genetics Pseudomonas aeruginosa - isolation & purification Pseudomonas aeruginosa - metabolism Pseudomonas aeruginosa - physiology Pseudomonas Infections - drug therapy Pseudomonas Infections - microbiology Quorum Sensing Success Thoracic surgery Tobramycin - therapeutic use Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!